Feature | October 15, 2014

Veterinary CyberKnife Cancer Center Opens Advanced Radiation Treatment Center for Pets in Malvern, Pa.

Veterinarians can now treat tumors not historically treated with radiation

October 15, 2014 — Veterinary CyberKnife Cancer Center (VC3), a privately owned advanced radiation treatment center for veterinary use, today announced the opening of its facility in Malvern, Pa. The CyberKnife is a non-invasive way to deliver radiation to tumors, enabling treatment with greater precision than traditional linear accelerators and intensity modulated radiation therapy (IMRT) machines. The CyberKnife delivers an entire therapeutic dose of radiation in one to three treatments versus 17 to 20 treatments of traditional radiation therapy. VC3 has changed the way companion animals with cancerous tumors are treated.

CyberKnife (manufactured by Accuray Inc. of Sunnyvale, Calif.), is also called stereotactic radiosurgery. It utilizes a sophisticated robotic arm that revolves around the animal, delivering precisely targeted radiation to the tumor while sparing healthy tissue and surrounding organs. The precision of the CyberKnife allows tumors that haven’t historically been treated with radiation in the veterinary field, such as lung and liver tumors, to be treated. The end result is more precise and far fewer treatments, a significantly reduced number of anesthetic episodes, fewer visits to the veterinarian and a better quality of life for the pet and owner.

“The CyberKnife offers the best clinical option for the majority of my patients undergoing palliative or definitive radiation treatment,” said Siobhan Haney, DVM., M.S., DACVR (RO), MBA. Haney is a veterinary radiation oncologist at Hope Veterinary Specialists in Malvern, Pa.

VC3 owns and operates one of only two CyberKnifes in the world devoted for veterinary use and the only CyberKnife for veterinary use in the Mid-Atlantic region.

For more information: www.vetcyberknife.com

 

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation